Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NIAID Centralized Sequencing Protocol

NCT03206099 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT03206099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03206099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NIAID Centralized Sequencing Protocol
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Observational
Overall status
Recruiting
Start date
July 31, 2017
Completion date
December 31, 2029
Enrollment
20,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atopy, autoimmunity, autoinflammation, primary immunodeficiency